KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Account Payables (2016 - 2025)

Fulgent Genetics' Change in Account Payables history spans 10 years, with the latest figure at $924000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 214.36% year-over-year to $924000.0; the TTM value through Dec 2025 reached $550000.0, down 82.06%, while the annual FY2025 figure was $550000.0, 82.06% down from the prior year.
  • Change in Account Payables for Q4 2025 was $924000.0 at Fulgent Genetics, up from -$102000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $7.0 million in Q4 2022 and bottomed at -$22.1 million in Q3 2022.
  • The 5-year median for Change in Account Payables is -$451500.0 (2024), against an average of -$2.0 million.
  • The largest YoY upside for Change in Account Payables was 318.23% in 2022 against a maximum downside of 1860.21% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at -$3.2 million in 2021, then surged by 318.23% to $7.0 million in 2022, then crashed by 98.16% to $129000.0 in 2023, then tumbled by 726.36% to -$808000.0 in 2024, then surged by 214.36% to $924000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Change in Account Payables are $924000.0 (Q4 2025), -$102000.0 (Q3 2025), and $386000.0 (Q2 2025).